Abstract Elastin-like recombinamers (ELRs), which derive from one of the repetitive domains
found in natural elastin, have been intensively studied in the last few years from several …

Synthetic polypeptides are biocompatible and biodegradable macromolecules whose
composition and architecture can vary over a wide range. Their unique ability to form …

Abstract In 2006, Shinya Yamanaka generated induced pluripotent stem cells (iPSCs),
which has been the major scientific event of the decade that caught the eye of many …

Simple Summary Gene therapy is one of the most promising approaches to treating various
inherited and acquired diseases by delivering genetic constructs into the cells and tissues of …

To realize the full potential of emerging nucleic acid therapies, there is a need for effective
delivery agents to transport cargo to cells of interest. Protein materials exhibit several unique …

The induced pluripotent stem cells (iPSCs) are derived from somatic cells by using
reprogramming factors such as Oct4, Sox2, Klf4, and c-Myc (OSKM) or Oct4, Sox2, Nanog …

About ninety percent of all diabetic conditions account for T2D caused due to abnormal
insulin secretion/action or increased hepatic glucose production. Factors that contribute …

Elastin-like polypeptides (ELPs) are macromolecular biopolymers composed of natural
amino acids. ELPs can be prepared by genetic engineering so that their amino acid …

In the past decade, induced pluripotent stem cells (iPSCs) technology has significantly
progressed in studying malignant solid tumors. This technically feasible reprogramming …

Nucleic acid-based therapeutics represent a revolutionary approach in treating genetic
disorders, offering unprecedented potential for addressing pathologies at their molecular …